文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

RNA-binding protein YBX1 promotes cell proliferation and invasiveness of nasopharyngeal carcinoma cells binding to AURKA mRNA.

作者信息

Ban Yuanyuan, Tan Yixin, Li Xiaoling, Li Xiayu, Zeng Zhaoyang, Xiong Wei, Li Guiyuan, Xiang Bo, Yi Mei

机构信息

Hunan Key Laboratory of Cancer Metabolism, Hunan Provincial Cancer Hospital and Cancer Hospital Affiliated to Xiangya Medical School, Central South University, Changsha 410013, Hunan, China.

The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute and School of Basic Medical Sciences, Central South University, Changsha 410078, Hunan, China.

出版信息

J Cancer. 2021 Apr 7;12(11):3315-3324. doi: 10.7150/jca.56262. eCollection 2021.


DOI:10.7150/jca.56262
PMID:33976741
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8100805/
Abstract

RNA-binding proteins (RBPs) play essential roles in post-transcriptional control of gene expression. Dysregulation of RBPs is intensively implicated in development and progression of human diseases, including cancers. However, the roles of RBPs in nasopharyngeal carcinoma (NPC), which is a distinct subtype of head and neck cancer, remain elusive. NPC-related RBPs were explored by analyzing GEO database and high-throughput proteomic data obtained from crosslinking immunoprecipitation. The expression levels of Y box binding protein 1 (YBX1) protein in NPC samples were measured by immunohistochemistry (IHC) staining. The association of YBX1 protein levels with prognosis of NPC patients was analyzed by Kaplan-Meier Plotter. The expression levels of YBX1 in NPC cells were inhibited by RNA interference. Cell growth was measured by CCK-8 assay. Cell mobility and invasiveness were measured by transwell assays. Tumorigenicity was measured by using a xenograft tumor assay. The expression levels of mRNAs or proteins were determined by qPCR or western blot assays, respectively. The mRNAs binding to YBX1 were determined by RNA immunoprecipitation (RIP) and qPCR. The effect of YBX1 on mRNA translation was measured by luciferase reporter assay. In the present study, we demonstrated a differentially expressed RBPs profile between NPC and its normal counterpart. Among these aberrantly expressed RBPs, YBX1 was overexpressed in NPC. We found that YBX1 is mainly localized in the cytoplasm of NPC cells. Loss of YBX1 led to reduced cell proliferation, migration and invasiveness , and reduced tumorigenicity . Overexpression of YBX1 associates with high expression of cell cycle G2/M checkpoint modulators. In addition, YBX1 promotes AURKA protein expression by directly binding to its mRNA. Loss of YBX1 leads to reduction of AURKA protein level. Forced expression of AURKA rescues cell proliferation and invasiveness in YBX1-silenced NPC cell. The current study indicated that YBX1 promotes NPC cell proliferation and invasiveness through enhancing protein synthesis of AURKA.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd0/8100805/5faf916ad462/jcav12p3315g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd0/8100805/451fa2b31929/jcav12p3315g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd0/8100805/4f29ff39dd3d/jcav12p3315g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd0/8100805/cc191b5eed21/jcav12p3315g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd0/8100805/45901e72da67/jcav12p3315g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd0/8100805/078b1e2bd435/jcav12p3315g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd0/8100805/3212d417b9c9/jcav12p3315g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd0/8100805/5faf916ad462/jcav12p3315g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd0/8100805/451fa2b31929/jcav12p3315g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd0/8100805/4f29ff39dd3d/jcav12p3315g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd0/8100805/cc191b5eed21/jcav12p3315g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd0/8100805/45901e72da67/jcav12p3315g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd0/8100805/078b1e2bd435/jcav12p3315g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd0/8100805/3212d417b9c9/jcav12p3315g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd0/8100805/5faf916ad462/jcav12p3315g007.jpg

相似文献

[1]
RNA-binding protein YBX1 promotes cell proliferation and invasiveness of nasopharyngeal carcinoma cells binding to AURKA mRNA.

J Cancer. 2021-4-7

[2]
LncRNA FOXD3-AS1 Promotes the Malignant Progression of Nasopharyngeal Carcinoma Through Enhancing the Transcription of YBX1 by H3K27Ac Modification.

Front Oncol. 2021-7-29

[3]
AURKA, as a potential prognostic biomarker, regulates autophagy and immune infiltration in nasopharyngeal carcinoma.

Immunobiology. 2023-3

[4]
LNCAROD is stabilized by m6A methylation and promotes cancer progression via forming a ternary complex with HSPA1A and YBX1 in head and neck squamous cell carcinoma.

Mol Oncol. 2020-6

[5]
High YBX1 expression indicates poor prognosis and promotes cell migration and invasion in nasopharyngeal carcinoma.

Exp Cell Res. 2017-12-1

[6]
Long non-coding RNA LINC01133 mediates nasopharyngeal carcinoma tumorigenesis by binding to YBX1.

Am J Cancer Res. 2019-4-1

[7]
Y-box binding protein 1/cyclin A1 axis specifically promotes cell cycle progression at G/M phase in ovarian cancer.

Sci Rep. 2024-9-17

[8]
The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis.

J Exp Clin Cancer Res. 2019-9-3

[9]
FOXA1 Suppresses the Growth, Migration, and Invasion of Nasopharyngeal Carcinoma Cells through Repressing miR-100-5p and miR-125b-5p.

J Cancer. 2020-2-10

[10]
Long noncoding RNA ZFAS1 promotes tumorigenesis and metastasis in nasopharyngeal carcinoma by sponging miR-892b to up-regulate LPAR1 expression.

J Cell Mol Med. 2020-1

引用本文的文献

[1]
YBX1: an RNA/DNA-binding protein that affects disease progression.

Front Oncol. 2025-7-29

[2]
YBX1 Modulates Intimal Hyperplasia by Regulating Expression and Alternative Splicing of Cell Cycle Associated Genes in RASMCs.

J Cell Mol Med. 2025-3

[3]
RNA-targeted proteomics identifies YBX1 as critical for efficient HCMV mRNA translation.

Proc Natl Acad Sci U S A. 2025-3-11

[4]
miR-379-5p Inhibited the Proliferation of Acute Myeloid Leukemia Cells Through Negative Regulation of .

Turk J Haematol. 2025-5-22

[5]
YBX1: A Multifunctional Protein in Senescence and Immune Regulation.

Curr Issues Mol Biol. 2024-12-13

[6]
Y-box binding protein 1/cyclin A1 axis specifically promotes cell cycle progression at G/M phase in ovarian cancer.

Sci Rep. 2024-9-17

[7]
ALYREF promotes the metastasis of nasopharyngeal carcinoma by increasing the stability of NOTCH1 mRNA.

Cell Death Dis. 2024-8-8

[8]
Single-cell RNA-seq mapping of chicken peripheral blood leukocytes.

BMC Genomics. 2024-1-29

[9]
Y-Box Binding Protein 1: Unraveling the Multifaceted Role in Cancer Development and Therapeutic Potential.

Int J Mol Sci. 2024-1-5

[10]
The multifaceted role of Fragile X-Related Protein 1 (FXR1) in cellular processes: an updated review on cancer and clinical applications.

Cell Death Dis. 2024-1-18

本文引用的文献

[1]
TP63 links chromatin remodeling and enhancer reprogramming to epidermal differentiation and squamous cell carcinoma development.

Cell Mol Life Sci. 2020-5-23

[2]
The tumor suppressor NOR1 suppresses cell growth, invasiveness, and tumorigenicity in glioma.

Neoplasma. 2020-3-30

[3]
LNCAROD is stabilized by m6A methylation and promotes cancer progression via forming a ternary complex with HSPA1A and YBX1 in head and neck squamous cell carcinoma.

Mol Oncol. 2020-6

[4]
FOXA1 Suppresses the Growth, Migration, and Invasion of Nasopharyngeal Carcinoma Cells through Repressing miR-100-5p and miR-125b-5p.

J Cancer. 2020-2-10

[5]
ΔNp63α is a super enhancer-enriched master factor controlling the basal-to-luminal differentiation transcriptional program and gene regulatory networks in nasopharyngeal carcinoma.

Carcinogenesis. 2020-9-24

[6]
EGFR-PKM2 signaling promotes the metastatic potential of nasopharyngeal carcinoma through induction of FOSL1 and ANTXR2.

Carcinogenesis. 2020-7-10

[7]
Identification of key pathways and genes in nasopharyngeal carcinoma using bioinformatics analysis.

Oncol Lett. 2019-5

[8]
FOXA1 reprograms the TGF-β-stimulated transcriptional program from a metastasis promoter to a tumor suppressor in nasopharyngeal carcinoma.

Cancer Lett. 2018-10-28

[9]
YBX1 at the crossroads of non-coding transcriptome, exosomal, and cytoplasmic granular signaling.

Eur J Cell Biol. 2018-2-19

[10]
Rediscovery of NF-κB signaling in nasopharyngeal carcinoma: How genetic defects of NF-κB pathway interplay with EBV in driving oncogenesis?

J Cell Physiol. 2018-1-19

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索